[go: up one dir, main page]

JP2010022667A - Cerebral blood flow analyzer - Google Patents

Cerebral blood flow analyzer Download PDF

Info

Publication number
JP2010022667A
JP2010022667A JP2008188979A JP2008188979A JP2010022667A JP 2010022667 A JP2010022667 A JP 2010022667A JP 2008188979 A JP2008188979 A JP 2008188979A JP 2008188979 A JP2008188979 A JP 2008188979A JP 2010022667 A JP2010022667 A JP 2010022667A
Authority
JP
Japan
Prior art keywords
curve
time
blood flow
shift
arterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008188979A
Other languages
Japanese (ja)
Inventor
Yoshihiro Ikeda
佳弘 池田
Naoko Toyoshima
直穂子 豊嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toshiba Corp
Canon Medical Systems Corp
Original Assignee
Toshiba Corp
Toshiba Medical Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toshiba Corp, Toshiba Medical Systems Corp filed Critical Toshiba Corp
Priority to JP2008188979A priority Critical patent/JP2010022667A/en
Publication of JP2010022667A publication Critical patent/JP2010022667A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Apparatus For Radiation Diagnosis (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To stably calculate a mean transit time of blood of a test site despite a time difference in contrast medium arrival times between the artery and a test region. <P>SOLUTION: This analyzer reconstructs a plurality of images with different imaging times collected by scanning a subject's site of interest where the contrast medium is administered, and analyzes the cerebral blood flow of the blood vessel in the brain tissue from the reconstructed image. This cerebral blood flow analyzer includes; a change curve creation means 26C for creating an artery curve and a test site curve indicating time-contrast medium density changes in the artery and the test site in the subject's brain tissue from a plurality of reconstruction images; a shift process means 26D shifting the created artery curve to the time axis negative direction closer than the test site curve; and a means 26E calculating the mean transit time of the blood flow of the test site from the artery curve and the test site curve after the shifting based on a blood flow transmission function model where a contrast medium arrival time in the test site is slower than the artery. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、X線CT装置やMRI(磁気共鳴イメージング)装置等に用いられる脳組織内の脳血流解析装置に係り、特に被検体に投与した造影剤の到達時刻により生ずる脳血流解析の影響を回避する脳血流解析装置に関する。   The present invention relates to an apparatus for analyzing cerebral blood flow in brain tissue used in an X-ray CT apparatus, an MRI (magnetic resonance imaging) apparatus, and the like, and in particular, an analysis of cerebral blood flow generated by the arrival time of a contrast medium administered to a subject. The present invention relates to a cerebral blood flow analysis device that avoids the influence.

従来、被検体(例えば患者)の脳組織内血管の脳血流を解析する場合、被検体に造影剤を投与した後、造影剤が被検体の関心部位を通過するまで、所定の間隔(ダイナミックインターバルという)でダイナミックスキャンを実施し、連続した複数枚の画像を取り出し、脳血流解析(CT−パフュージョン(perfusion))を行う方法が提案されている(特許文献1)。   Conventionally, when analyzing cerebral blood flow of blood vessels in a brain tissue of a subject (for example, a patient), after a contrast agent is administered to the subject, a predetermined interval (dynamic) is passed until the contrast agent passes through the region of interest of the subject. A method has been proposed in which dynamic scanning is performed at intervals), a plurality of continuous images are taken out, and cerebral blood flow analysis (CT-perfusion) is performed (Patent Document 1).

この脳血流解析方法は、造影剤を投与した被検体の例えば頭部(全被検査領域)を反復して撮影し、連続した複数枚のダイナミックCT画像を作成する。そして、作成された複数枚のダイナミックCT画像から被検体頭部の関心部位である動脈毎及び各被検査部位毎のCT値の経時変化を表す時間−濃度(CT値)曲線を取得し、脳血流の解析を行う方法である。   In this cerebral blood flow analysis method, for example, the head (all examination regions) of a subject to which a contrast medium is administered is repeatedly imaged, and a plurality of continuous dynamic CT images are created. Then, a time-concentration (CT value) curve representing a time-dependent change in the CT value for each artery and each region to be examined, which is a region of interest on the subject's head, is obtained from the created dynamic CT images, and the brain This is a method for analyzing blood flow.

ここで、脳血流解析としては、CT値曲線を用いて、脳血流量(CBP:脳素組織の毛細血管内の単位体積及び単位時間当りの血流量)、脳血液量(CBV:Cerebral Blood Volume:脳組織内の単位体積当りの血液量)、平均通過時間(MTT:Mean Transit Time:毛細血管の血液平均通過時間)などを算出する。
特開2003−190148号公報
Here, as the cerebral blood flow analysis, using a CT value curve, cerebral blood flow (CBP: unit volume and blood flow per unit time in capillaries of brain tissue), cerebral blood volume (CBV: Cerebral Blood). Volume: blood volume per unit volume in brain tissue), mean transit time (MTT: Mean Transit Time: mean blood transit time of capillaries) and the like are calculated.
JP 2003-190148 A

ところで、以上のような脳血流解析方法は、被検体に造影剤を投与した後、造影剤が被検体の関心部位である動脈及び各検査部位を通過するまで、連続的に所定枚数の透過画像を取り込んで再構成し表示する。そして、図7(a)に示すようにユーザが頭部100内の特定の動脈101を指定し、同図(b)に示す動脈のCT値の経時変化を表す時間−濃度曲線(動脈の造影剤濃度変化曲線:以下、動脈曲線Caと呼ぶ)及び各被検査部位のCT値の経時変化を表す時間−濃度曲線(被検査部位の造影剤濃度変化曲線:以下、被検査部位曲線Ciと呼ぶ)を作成する。   By the way, in the above cerebral blood flow analysis method, after a contrast agent is administered to a subject, a predetermined number of transmissions are continuously performed until the contrast agent passes through an artery and each examination site that are the subject's interest. Capture, reconstruct and display images. Then, as shown in FIG. 7 (a), the user designates a specific artery 101 in the head 100, and a time-concentration curve (arterial contrast image) representing the temporal change in the CT value of the artery shown in FIG. 7 (b). Agent concentration change curve: hereinafter referred to as arterial curve Ca) and time-concentration curve representing the time-dependent change in CT value of each site to be examined (contrast medium concentration change curve of site to be examined: hereinafter referred to as site curve Ci to be examined) ).

このとき、通常,造影剤で染まった血液は、心臓、肺を経由し、動脈101を通った後、脳組織内の各被検査部位102へ流れ込んでいくので、先に動脈101に関するCTピーク値をもった動脈曲線Caが現れ、この動脈曲線Caとほぼ同じか、それよりも遅れて各被検査部位102に関するCTピーク値をもった被検査部位曲線Ciが現れる。   At this time, the blood stained with the contrast medium normally passes through the heart and lungs, passes through the artery 101, and then flows into each of the inspected sites 102 in the brain tissue. An arterial curve Ca having a CT peak value with respect to each of the inspected sites 102 appears with a delay approximately equal to or later than the arterial curve Ca.

因みに、動脈曲線Caと脳組織内の被検査部位曲線Ciとの関係から脳組織内の血液の平均通過時間MTTを伝達関数で表すと、模式的には図8に示すように表すことができる。   Incidentally, when the average transit time MTT of blood in the brain tissue is represented by a transfer function from the relationship between the arterial curve Ca and the inspected site curve Ci in the brain tissue, it can be schematically represented as shown in FIG. .

すなわち、脳動脈曲線Caと脳組織内の被検査部位曲線Ciが造影剤の投与開始直後にほぼ同じCT値分布で立ち上がった後にほぼ同じピーク値から降下したとき、造影剤の投与開始直後にパルス状となる伝達関数で表すことができる(図8(a)参照)。また、脳動脈曲線Caが脳組織内の被検査部位曲線Ciよりも先にほぼ同じCT値分布で現れたとき、造影剤の投与開始点からある時間経過後にパルス状の伝達関数で表すことができる(図8(b)参照)。また、両曲線Ca,Ciが造影剤の投与開始直後に正負方向に立ち上がり特性を示しながら脳組織内の被検査部位曲線CiのCTピーク値が小さくなったとき、それに伴って低いパルス状となる伝達関数で表すことができる(図8(c)参照)。   That is, when the cerebral artery curve Ca and the to-be-inspected curve Ci in the brain tissue rise with substantially the same CT value distribution immediately after the start of the administration of the contrast agent and then drop from substantially the same peak value, the pulse immediately after the start of the administration of the contrast agent Can be represented by a transfer function (see FIG. 8A). Further, when the cerebral artery curve Ca appears with substantially the same CT value distribution before the inspected site curve Ci in the brain tissue, it can be expressed by a pulse-like transfer function after a lapse of time from the administration start point of the contrast agent. (See FIG. 8B). Further, when both the curves Ca and Ci rise in the positive and negative directions immediately after the start of administration of the contrast agent and the CT peak value of the region curve Ci to be examined in the brain tissue becomes small, it becomes a low pulse accordingly. It can be expressed by a transfer function (see FIG. 8C).

さらに、脳動脈曲線Caと脳組織内の被検査部位曲線Ciとの造影剤濃度ピーク到達時刻が離れるに従って、造影剤の投与開始点からある時間経過後に理想的な矩形波の伝達関数で表すことができる(図8(d)参照)。   Further, as the contrast agent concentration peak arrival time between the cerebral artery curve Ca and the inspected site curve Ci in the brain tissue is separated, it is expressed by an ideal rectangular wave transfer function after a lapse of time from the administration start point of the contrast agent. (See FIG. 8D).

しかし、脳動脈曲線Caが脳組織内の被検査部位曲線Ciよりも遅く立ち上がった場合には伝達関数モデルが成立しなくなる(図8(e)参照)。   However, when the cerebral artery curve Ca rises later than the inspected site curve Ci in the brain tissue, the transfer function model is not established (see FIG. 8E).

このことは、何らかの理由により指定動脈101に異常が生じている場合、被検査部位102に関する被検査部位曲線Ciが先に現れ、その後に指定動脈101の脳動脈曲線Caが現れることがある。   This is because, when an abnormality occurs in the designated artery 101 for some reason, the examination site curve Ci related to the examination site 102 may appear first, and then the cerebral artery curve Ca of the designated artery 101 may appear.

本来、被検査部位102の血液の平均通過時間MTTは、造影剤で染まった血液が動脈101に達する到達時間とある特定の被検査部位102に達する到達時間との時間差から算出されることから、図8(e)のように動脈101の曲線Caが被検査部位102の被検査部位曲線Ciよりも遅れて現れる場合、被検査部位102における血液の平均通過時間の解析精度が大きく低下し、脳血流の解析が不能となる。   Originally, the average passage time MTT of blood in the region to be inspected 102 is calculated from the time difference between the arrival time at which the blood stained with the contrast medium reaches the artery 101 and the arrival time to reach a specific region to be inspected 102, As shown in FIG. 8E, when the curve Ca of the artery 101 appears later than the to-be-inspected part curve Ci of the to-be-inspected part 102, the analysis accuracy of the average passage time of blood in the to-be-inspected part 102 is greatly reduced, Analysis of blood flow becomes impossible.

本発明は上記事情に鑑みてなされたもので、動脈と被検査領域との造影剤到達時刻の時間差によらず、被検査部位の血液の平均通過時間を安定に算出する脳血流解析装置を提供することを目的とする。   The present invention has been made in view of the above circumstances, and provides a cerebral blood flow analysis device that stably calculates the average passage time of blood in a region to be examined regardless of the time difference in contrast agent arrival time between the artery and the region to be examined. The purpose is to provide.

上記課題を解決するために、造影剤が投与された被検体の関心部位をスキャンして得られた撮影時間の異なる複数の画像に基づいて脳組織内の血流を解析する脳血流解析装置において、前記複数の画像から前記被検体の関心部位となる脳組織内の動脈及び被検査部位の時間−造影剤濃度変化を表す動脈曲線及び被検査部位曲線を作成する変化曲線作成手段と、この変化曲線作成手段により作成された動脈曲線を、前記被検査部位曲線よりも時間軸負方向へシフトする動脈曲線シフト処理手段と、前記被検査部位の造影剤到達時刻が前記動脈よりも遅い血流伝達関数モデルに基づき、前記シフト後の前記動脈曲線と前記被検査部位曲線とから前記被検査部位の血流の平均通過時間を算出する手段とを備えた脳血流解析装置である。   In order to solve the above problems, a cerebral blood flow analysis device that analyzes blood flow in a brain tissue based on a plurality of images having different imaging times obtained by scanning a region of interest of a subject to which a contrast medium is administered And an arterial curve representing the time-contrast agent concentration change of the artery in the brain tissue that is the region of interest of the subject and the region to be examined from the plurality of images, and a change curve creating unit that creates the region to be examined, Arterial curve shift processing means for shifting the arterial curve created by the change curve creating means in the negative direction of the time axis with respect to the examination site curve, and blood flow whose contrast medium arrival time at the examination site is later than that of the artery A cerebral blood flow analysis device comprising: means for calculating an average transit time of blood flow of the examined region from the arterial curve after the shift and the examined region curve based on a transfer function model.

本発明によれば、動脈と被検査領域との造影剤到達時刻の時間差によらず、被検査部位の血液の平均通過時間を安定に算出することができる。   According to the present invention, it is possible to stably calculate the average passage time of blood in a region to be examined regardless of the time difference in the contrast agent arrival time between the artery and the region to be examined.

以下、本発明の実施の形態について図面を参照して説明する。
図1は本発明に係るX線CT装置における脳血流解析装置の一実施の形態を示す構成図である。
Hereinafter, embodiments of the present invention will be described with reference to the drawings.
FIG. 1 is a configuration diagram showing an embodiment of a cerebral blood flow analysis apparatus in an X-ray CT apparatus according to the present invention.

この脳血流解析装置は、被検体関心部位画像検出装置10と脳血流解析装置本体部20とで構成される。   This cerebral blood flow analysis device includes a subject region-of-interest image detection device 10 and a cerebral blood flow analysis device main body 20.

被検体関心部位画像検出装置10としては、被検体から時系列的に連続する複数枚の画像を発生させるものであって、特定の装置に限定されるものでなく、例えばX線CT装置(X線コンピュータトモグラフィ装置)、シングルフォトンエミッショントモグラフィ装置(SPECT装置)、ポジトロンエミッショントモグラフィ装置(PET装置)、MRI装置の何れか1つが用いられるが、ここでは便宜上、X線CT装置を用いた例について説明する。   The subject region-of-interest image detection apparatus 10 generates a plurality of continuous images in time series from the subject, and is not limited to a specific apparatus. For example, an X-ray CT apparatus (X Any one of a line computer tomography apparatus), a single photon emission tomography apparatus (SPECT apparatus), a positron emission tomography apparatus (PET apparatus), and an MRI apparatus is used. For convenience, an X-ray CT apparatus is used here. An example will be described.

X線CT装置としては、X線発生器11と2次元の検出チャンネルを有するX線検出器12との間に被検体13(患者)を載置したテーブル14が配置され、X線発生器11から被検体13の例えば頭部13aに向けてX線が照射される。   As the X-ray CT apparatus, a table 14 on which a subject 13 (patient) is placed is disposed between an X-ray generator 11 and an X-ray detector 12 having a two-dimensional detection channel. X-rays are irradiated from, for example, toward the head 13 a of the subject 13.

2次元のX線検出器12は、被検体13の頭部13aから透過してくるX線透過データを2次元的に検出し、デジタル透過データとして脳血流解析装置本体部20に送出するか、あるいは脳血流解析装置本体部20の読み込み指示に従ってデジタル透過データが収集される。   Whether the two-dimensional X-ray detector 12 detects X-ray transmission data transmitted from the head 13a of the subject 13 two-dimensionally and sends it to the cerebral blood flow analyzer main body 20 as digital transmission data. Alternatively, digital transmission data is collected in accordance with a reading instruction from the cerebral blood flow analyzer main body 20.

15はX線検出器12に対して所望の管電圧及び管電流を設定する高電圧発生装置である。   A high voltage generator 15 sets a desired tube voltage and tube current for the X-ray detector 12.

すなわち、被検体関心部位画像検出装置10は、回転リングにX線発生器11とX線検出器12とを互いに対向するように設置し、テーブル14上の被検体13の頭部13aを挟んだ状態に設定し、X線発生器11からX線を照射した状態で回転リングを高速、かつ、回転させつつ、頭部13aを透過してくるX線透過データを連続的に2次元X線検出器12で検出し、異なる投影方向に対応する複数のデジタル的なX線透過データを取得する。   That is, the subject region-of-interest image detection apparatus 10 is installed such that the X-ray generator 11 and the X-ray detector 12 face each other on a rotating ring and sandwich the head 13a of the subject 13 on the table 14. The X-ray transmission data transmitted through the head 13a is continuously detected in a two-dimensional manner while rotating the rotating ring at a high speed while the X-ray generator 11 is irradiated with the X-rays. A plurality of digital X-ray transmission data detected by the instrument 12 and corresponding to different projection directions are acquired.

脳血流解析装置本体部20は、コンピュータ装置によって構成され、ハードウエア的には、インターフェース21、このインターフェース21に連なるバス22に各種の機能ユニットが接続されている。   The cerebral blood flow analysis device main body 20 is constituted by a computer device, and various functional units are connected to an interface 21 and a bus 22 connected to the interface 21 in terms of hardware.

この機能ユニットとしては、透過データ収集指示、画像再構成指示、脳組織内の血流解析処理上必要な各種データの設定、その他各種の制御指示などを入力するキーボード,ポインティングデバイスなどの操作部23、連続的な複数枚のX線透過データを収集し記憶する記憶装置24、収集したX線透過データの再構成画像及び各種の処理画像を表示する画像表示部25、脳組織内の血流の解析処理を実行するCPUで構成される画像解析処理部26、ROM27及びRAM28などで構成される。   This functional unit includes an operation unit 23 such as a keyboard or pointing device for inputting transmission data collection instructions, image reconstruction instructions, setting of various data necessary for blood flow analysis processing in brain tissue, and other various control instructions. A storage device 24 that collects and stores a plurality of continuous X-ray transmission data, an image display unit 25 that displays a reconstructed image of the acquired X-ray transmission data and various processed images, and a blood flow in the brain tissue The image analysis processing unit 26 includes a CPU that executes analysis processing, a ROM 27, a RAM 28, and the like.

画像解析処理部26は、記憶装置24に記憶された被検体13の関心領域(例えば頭部13a)の複数枚の画像に基づいて、脳組織の血流解析処理用プログラムに従ってかかる部位の組織血流(パフュージョン)の動態を解析処理するものである。   Based on a plurality of images of the region of interest (for example, the head 13 a) of the subject 13 stored in the storage device 24, the image analysis processing unit 26 performs tissue blood at the site according to a blood flow analysis processing program for brain tissue. It analyzes flow (perfusion) dynamics.

ROM27には脳組織の血流解析処理用プログラムが記憶される。RAM28には画像解析処理部26で処理される脳組織内血流の解析処理途中、処理結果等の画像、情報を一時的に記憶する。   The ROM 27 stores a blood flow analysis processing program for brain tissue. The RAM 28 temporarily stores images and information such as processing results during the analysis processing of blood flow in the brain tissue processed by the image analysis processing unit 26.

前記画像解析処理部26としては、機能的には図2に示すように、連続的な複数枚のX線透過データを収集し表示する透過データ収集手段26Aと、収集されたX線透過データに基づいて画像を再構成する再構成処理手段26Bと、ユーザによって指定された特定の動脈曲線(動脈のCT値の経時変化を表す時間−濃度曲線)及び脳組織内の各被検査部位曲線(各被検査部位のCT値の経時変化を表す時間−濃度曲線)を作成する変化曲線作成手段としてのCT値曲線作成手段26Cと、このCT値曲線作成手段26Cで作成された動脈曲線を時間軸負方向へシフトする動脈曲線シフト処理手段26Dと、血流量算出手段26Eとが設けられている。   As shown in FIG. 2, the image analysis processing unit 26 functionally collects a plurality of continuous X-ray transmission data and displays the transmission data collection means 26A, and collects the collected X-ray transmission data. A reconstruction processing means 26B for reconstructing an image based on the image, a specific arterial curve designated by the user (a time-concentration curve representing a temporal change in the CT value of the artery), and each inspected site curve in the brain tissue (each CT value curve creating means 26C as a change curve creating means for creating a time-concentration curve representing a time-dependent change in CT value of a region to be inspected, and an arterial curve created by this CT value curve creating means 26C is negative on the time axis. Arterial curve shift processing means 26D that shifts in the direction and blood flow rate calculation means 26E are provided.

なお、被検体関心部位画像検出装置10が例えばX線CT装置であれば、当該X線CT装置自体で透過データ収集手段26A及び再構成処理手段26Bを実行し、脳血流解析装置本体部20は、再構成された画像を取得する場合もあり得る。   If the subject region-of-interest image detection apparatus 10 is, for example, an X-ray CT apparatus, the X-ray CT apparatus itself executes the transmission data collection means 26A and the reconstruction processing means 26B, and the cerebral blood flow analysis apparatus main body 20 May obtain a reconstructed image.

次に、以上のように構成された脳血流解析装置の作用について、図3を参照して説明する。   Next, the operation of the cerebral blood flow analysis apparatus configured as described above will be described with reference to FIG.

まず、被検体関心部位画像検出装置10により、被検体13の例えば頭部13aの所望断面にダイナミックスキャンが実行される。このスキャンに際して、被検体13に脳血管透過性を持たないX線造影剤を急速投与する。この造影剤は、心臓、肺を経由して脳動脈に流れ込み、この動脈流から脳組織内の各検査部位を通り、脳静脈に流れ出る。   First, the subject region-of-interest image detection apparatus 10 performs a dynamic scan on a desired cross section of the subject 13, for example, the head 13a. At the time of this scan, an X-ray contrast agent having no cerebral vascular permeability is rapidly administered to the subject 13. This contrast agent flows into the cerebral artery via the heart and lungs, and flows out from the arterial flow to each cerebral vein through each examination site in the brain tissue.

ここで、脳血流解析装置本体部20は、ユーザが操作部23から収集指示を入力すると、画像解析処理部26は、透過データ収集手段26Aを実行する。   Here, when the user inputs a collection instruction from the operation unit 23, the image analysis processing unit 26 executes the transmission data collection unit 26A.

この透過データ収集手段26Aは、前述したダイナミックスキャンにより、一定時間毎又は連続的に被検体13の頭部13aの所望断面における異なる投影方向に対応するX線透過データ(生データ)を収集し、記憶装置24に順次記憶していく(S1)。   The transmission data collection unit 26A collects X-ray transmission data (raw data) corresponding to different projection directions in the desired cross section of the head 13a of the subject 13 by the above-described dynamic scan at regular time intervals or continuously. The data is sequentially stored in the storage device 24 (S1).

X線透過データを収集した後、再構成処理手段26Bを実行する。再構成処理手段26Bは、再構成処理用プログラムに従い、収集したX線透過データを用いて再構成し、脳血流解析のためのダイナミックCT画像とし、記憶装置24の所定領域に記憶する(S2)。   After collecting the X-ray transmission data, the reconstruction processing means 26B is executed. The reconstruction processing means 26B reconstructs using the collected X-ray transmission data in accordance with the reconstruction processing program, creates a dynamic CT image for cerebral blood flow analysis, and stores it in a predetermined area of the storage device 24 (S2). ).

なお、ステップS1,S2による一連の処理は、被検体関心部位画像検出装置10側でダイナミックCT画像(再構成画像)を作成する場合には、脳血流解析装置本体部20は、撮影時間の異なる時間的に連続した当該ダイナミックCT画像を所定枚数(例えば40枚)収集し記憶装置24の所定領域に記憶するものとする。このダイナミックCT画像は、所望断面における造影剤の挙動情報(時間経過に伴う変化情報)を反映した画像になる。尚、ダイナミックCT画像は、一断面の画像のみではなく、3次元的な空間領域に対応する画像とすることもできる。   The series of processes in steps S1 and S2 is performed when the dynamic blood flow image (reconstructed image) is created on the subject region-of-interest image detection apparatus 10 side. It is assumed that a predetermined number (for example, 40) of dynamic CT images consecutive in different times are collected and stored in a predetermined area of the storage device 24. This dynamic CT image is an image reflecting the behavior information (change information with time) of the contrast agent in the desired cross section. Note that the dynamic CT image may be an image corresponding to a three-dimensional spatial region as well as an image of one cross section.

画像解析処理部26は、脳組織内血管の脳血流の解析に必要な条件が整ったとき、ユーザによる脳血流の解析指示を受けると、ROM27から血流解析処理用プログラムを読み出して例えば記憶装置24に書き込んだ後、血流解析処理用プログラムに従い、CT値曲線作成手段26Cを実行する。   When the conditions necessary for the analysis of the cerebral blood flow of the blood vessels in the cerebral tissue are satisfied, the image analysis processing unit 26 reads the blood flow analysis processing program from the ROM 27 when receiving a cerebral blood flow analysis instruction from the user. After writing in the storage device 24, the CT value curve creating means 26C is executed in accordance with the blood flow analysis processing program.

すなわち、CT値曲線作成手段26Cは、記憶装置24から複数枚(例えば40枚)のダイナミックCT画像を読み出し(S3)、ノイズ除去等を行った後、画像表示部25に表示する(S4)。   That is, the CT value curve creating means 26C reads a plurality of (for example, 40) dynamic CT images from the storage device 24 (S3), performs noise removal, and displays them on the image display unit 25 (S4).

そして、複数枚のダイナミックCT画像に対して、ユーザが操作部23を介して動脈31の指定有りかを判断し(S5)、指定有りの場合には当該指定動脈31に関するCT値(造影剤濃度値)を、画像毎に時系列的に読み取り、指定動脈のCT値の経時変化を表す時間−造影剤濃度曲線である動脈曲線Caを作成し、同様に関心部位である頭部14の脳組織内の各被検査部位のCT値の経時変化を表す時間−造影剤濃度曲線である被検査部位曲線Ciを作成した後(S6)、動脈曲線シフト処理手段26Dを実行する。   Then, for a plurality of dynamic CT images, the user determines whether or not the artery 31 is designated via the operation unit 23 (S5), and if designated, the CT value (contrast agent concentration) for the designated artery 31 is designated. Value) for each image in a time-series manner to create an arterial curve Ca that is a time-contrast agent concentration curve representing a time-dependent change in the CT value of the designated artery, and similarly, brain tissue of the head 14 that is the region of interest. After creating a region-of-inspection curve Ci that is a time-contrast medium concentration curve representing a time-dependent change in CT value of each region to be examined (S6), the arterial curve shift processing means 26D is executed.

この動脈曲線シフト処理手段26Dは、CT値曲線作成手段26Cにより作成された動脈曲線Ca及び被検査部位曲線Ciをそれぞれ解析し、これら動脈曲線Ca、被検査部位曲線Ciから、少なくとも造影剤が指定動脈31に到達する動脈曲線Caの立ち上がり時刻(開始時刻)ta及び造影剤が被検査部位に到達する被検査部位曲線の立ち上がり時刻(開始時刻)tiを算出する(S7)。   The arterial curve shift processing unit 26D analyzes the arterial curve Ca and the inspected site curve Ci created by the CT value curve creating unit 26C, respectively, and at least a contrast agent is designated from the arterial curve Ca and the inspected site curve Ci. The rise time (start time) ta of the arterial curve Ca reaching the artery 31 and the rise time (start time) ti of the test site curve where the contrast medium reaches the test site are calculated (S7).

なお、被検査部位曲線Ciの立ち上がり時間の算出は、被検査部位曲線Ci(t)または当該曲線Ci(t)における時間方向の微分値dCi(t)が予め定める設定値よりも大きくなる時刻を立ち上がり時刻tiとしてもよい。また、時間軸方向に平滑化を行うとか、被検査部位曲線全体や曲線の一部を多項式やガンマ関数などに当てはめ、立ち上がり時刻tiを算出してもよい。   In addition, the rise time of the inspected part curve Ci is calculated by calculating the time when the inspected part curve Ci (t) or the differential value dCi (t) in the time direction of the curve Ci (t) is larger than a predetermined set value. The rise time ti may be used. Further, the rising time ti may be calculated by performing smoothing in the time axis direction, or by applying the whole curve to be inspected or a part of the curve to a polynomial or a gamma function.

被検査部位曲線Ci(t)を求めるに際しては、ある特定の画素(ピクセル)における造影剤濃度変化曲線でなくてもよく、例えばある設定領域内の複数の画素の平均値を用いてもよい。   When obtaining the region-of-inspection curve Ci (t), it may not be a contrast agent concentration change curve in a specific pixel (pixel), and for example, an average value of a plurality of pixels in a certain setting region may be used.

動脈曲線Ca(t)の立ち上がりについても、被検査部位曲線Ciの場合と同様の手法により算出してもよい。   The rise of the arterial curve Ca (t) may be calculated by the same method as in the case of the inspected site curve Ci.

さらに、動脈曲線シフト処理手段26Dは、立ち上がり時刻(開始時刻)ta,tiを算出した後、次のようなシフト方法により動脈曲線Caをシフトする。   Further, the arterial curve shift processing means 26D calculates the rise time (start time) ta, ti, and then shifts the arterial curve Ca by the following shift method.

(1) 動脈曲線Caの立ち上がり時刻taと被検査部位曲線の立ち上がり時刻tiとを比較し、動脈曲線Caの立ち上がり時刻taが被検査部位曲線Ciの立ち上がり時刻tiよりも遅いと判断したとき、動脈曲線Caが被検査部位曲線Ciの立ち上がり時刻tiよりも時間軸負方向のある時刻から立ち上がるように平行移動量tsを算出する(S8)。 (1) When the rise time ta of the arterial curve Ca is compared with the rise time ti of the examination site curve, and it is determined that the rise time ta of the arterial curve Ca is later than the rise time ti of the examination site curve Ci The parallel movement amount ts is calculated so that the curve Ca rises from a certain time in the negative direction of the time axis relative to the rise time ti of the inspected site curve Ci (S8).

そして、動脈曲線Caを時間時負方向に平行移動量ts分シフト(平行移動)させることにより、図4(a)に示すようなシフトした動脈曲線Ca´を作成する(S9)。   Then, the arterial curve Ca is shifted (translated) by the parallel movement amount ts in the negative direction in time, thereby creating a shifted arterial curve Ca ′ as shown in FIG. 4A (S9).

(2) また、他のシフト方法としては、予めソフト的に動脈曲線Caの立ち上がり時刻taを被検査部位曲線Ciの立ち上がり時刻tiとするか、あるいは当該時刻tiよりも時間軸負方向にシフトするような処理を実施してもよい。このように動脈曲線Caの立ち上がり時刻を、被検査部位曲線Ciの立ち上がり時刻tiよりもtd(≧0)時間軸負方向にシフトする場合、動脈曲線Caのシフト量ts(<0の時)は、ts=ti−td−taから算出する。 (2) Further, as another shift method, the rise time ta of the arterial curve Ca is set in advance as the rise time ti of the inspected site curve Ci in software, or the time axis ti is shifted in the negative direction of the time axis. Such processing may be performed. In this way, when the rise time of the arterial curve Ca is shifted in the negative direction of the time axis by td (≧ 0) from the rise time ti of the site curve Ci, the shift amount ts (when <0) of the arterial curve Ca is , Ts = ti−td−ta.

すなわち、予めソフト的にシフト前の動脈曲線Caの立ち上がり時刻を、被検査部位曲線Ciの立ち上がり時刻、あるいは撮影開始時刻まで時間軸負方向へシフトすることが定められている場合、シフト前の動脈曲線Caを被検査部位曲線Ciの立ち上がり時刻、あるいは造影剤投与開始時刻まで時間軸負方向へ平行にシフトする平行移動量を算出し、この算出された移動量に従ってシフト前の動脈曲線を時間軸負方向へシフトし、このシフト後の動脈曲線を作成する。   That is, when it is determined in advance that the rise time of the arterial curve Ca before the shift is softly shifted in the negative direction of the time axis until the rise time of the inspected site curve Ci or the imaging start time, the artery before the shift is determined. The parallel movement amount that shifts the curve Ca in parallel in the negative direction of the time axis until the rise time of the inspected site curve Ci or the contrast agent administration start time is calculated. Shift in the negative direction and create the arterial curve after this shift.

なお、ts≧0の時は、ts=0とし、動脈曲線Caをシフトしなくてもよい。動脈曲線Ca(t)を時間軸方向にts分シフトした場合、Ca´(t)=Ca(t−ts)となる。   When ts ≧ 0, ts = 0 and the arterial curve Ca does not have to be shifted. When the arterial curve Ca (t) is shifted by ts in the time axis direction, Ca ′ (t) = Ca (t−ts).

さらに、画像解析処理部26は血流量算出手段26Eを実行する。この血流量算出手段26Eは、前記被検査部位の造影剤到達時刻が前記動脈よりも遅い血流伝達関数モデル(図4(b)参照)に基づき、デコンボリューション操作により、脳組織内の被検査部位曲線Ciの平均通過時間MTTを算出し、また、従来周知の算出方法を用いて血流量を算出する(S10)。   Further, the image analysis processing unit 26 executes a blood flow rate calculation unit 26E. This blood flow rate calculation means 26E is based on a blood flow transfer function model (see FIG. 4B) in which the contrast medium arrival time at the site to be examined is later than that of the artery, and is examined in the brain tissue by a deconvolution operation. The average transit time MTT of the part curve Ci is calculated, and the blood flow rate is calculated using a conventionally known calculation method (S10).

なお、造影剤の遅延を考慮したデコンボリューションとして、SVD法など伝達関数の形状を規定しない手法を用いるか、あるいは伝達関数モデルに当てはめる場合には図5に示すように遅延時間delayをパラメータとして伝達関数モデルに組み入れて解析を行ってもよい。   As a deconvolution considering the delay of the contrast agent, a method that does not define the shape of the transfer function such as the SVD method is used, or when applying to the transfer function model, the delay time delay is transmitted as a parameter as shown in FIG. Analysis may be performed by incorporating the function model.

従って、以上のような実施の形態によれば、少なくとも動脈曲線Caの立ち上がり時刻が被検査部位曲線Ciの立ち上がり時刻よりも遅い場合、動脈曲線Caを被検査部位曲線よりも時間軸負方向の時刻から立ち上がるように平行移動するようにシフトする。そして、被検査部位の造影剤到達時刻が動脈よりも遅い血流伝達関数モデルに基づき、脳組織内の被検査部位曲線Ciの平均通過時間MTTを算出するので、動脈と被検査領域との造影剤到達時刻の時間差によらず、常に安定に各被検査部位の造影剤平均通過時間MTTを算出できる。   Therefore, according to the embodiment as described above, when at least the rise time of the arterial curve Ca is later than the rise time of the inspected site curve Ci, the arterial curve Ca is time in the negative direction of the time axis from the inspected site curve. Shift to move parallel to get up from. Since the average transit time MTT of the region curve Ci to be examined in the brain tissue is calculated based on the blood flow transfer function model in which the contrast agent arrival time of the region to be examined is later than that of the artery, the contrast between the artery and the region to be examined is calculated. Regardless of the time difference in the agent arrival time, the contrast agent average passage time MTT of each site to be inspected can always be calculated stably.

因みに、動脈曲線Caの立ち上がり時刻が被検査部位曲線Ciの立ち上がり時刻よりも遅いにも拘らず、動脈曲線Caをシフトなし状態とした場合、図6(a)に示すように脳血流の解析画像の左側が解析不能となり、真っ赤なマップ(図では薄黒色)となってしまうが、動脈曲線Caをシフトした場合には同図(b)に示すように正常な解析画像を得ることができる。   Incidentally, when the arterial curve Ca is in a non-shift state although the rise time of the arterial curve Ca is later than the rise time of the region curve Ci to be examined, an analysis of cerebral blood flow is performed as shown in FIG. The left side of the image becomes unanalyzable and becomes a red map (light black in the figure), but when the arterial curve Ca is shifted, a normal analysis image can be obtained as shown in FIG. .

その他、本発明は、上記実施の形態に限定されるものでなく、その要旨を逸脱しない範囲で種々変形して実施することが可能である。 In addition, the present invention is not limited to the above-described embodiment, and various modifications can be made without departing from the scope of the invention.

本発明に係る脳血流解析装置の一実施の形態を示す構成図。The block diagram which shows one Embodiment of the cerebral blood-flow analysis apparatus which concerns on this invention. 図1の画像解析処理部の機能構成を示す図。The figure which shows the function structure of the image analysis process part of FIG. 図1の画像解析処理部の一連の処理の流れを説明する図。The figure explaining the flow of a series of processes of the image analysis process part of FIG. シフト後の動脈曲線と被検査部位曲線との関係から得られる伝達関数モデル図。The transfer function model figure obtained from the relationship between the arterial curve after a shift, and a to-be-inspected part curve. 遅延時間delayをパラメータとして表した伝達関数モデル図。The transfer function model figure which represented delay time delay as a parameter. 動脈曲線をシフト無しの状態とシフトした状態の血流解析画像を示す図。The figure which shows the blood-flow analysis image of the state which shifted the arterial curve to the state without a shift. 従来例を説明する被検体の関心部位と当該関心部位である動脈曲線及び被検査部位曲線との関係を説明する図。The figure explaining the relationship between the site | part of interest of the subject explaining a prior art example, the arterial curve which is the said site of interest, and a to-be-examined site | part curve. 動脈曲線と被検査部位曲線との関係から表した模式的な伝達関数モデル図。The typical transfer function model figure represented from the relationship between an arterial curve and a to-be-inspected part curve.

符号の説明Explanation of symbols

10…被検体関心部位画像検出部、11…X線発生器、12…X線検出器、13…被検体、13a…関心部位である頭部、20…脳血流解析装置本体部、23…操作部、24…記憶装置、25…画像表示部、26…画像解析処理部、26A…透過データ収集手段、26B…再構成処理手段、26C…CT値曲線作成手段、26D…動脈曲線シフト処理手段、26E…血流量算出手段。   DESCRIPTION OF SYMBOLS 10 ... Subject interest part image detection part, 11 ... X-ray generator, 12 ... X-ray detector, 13 ... Subject, 13a ... Head part which is a part of interest, 20 ... Cerebral blood flow analysis apparatus main part, 23 ... Operation unit, 24 ... storage device, 25 ... image display unit, 26 ... image analysis processing unit, 26A ... transmission data collection unit, 26B ... reconstruction processing unit, 26C ... CT value curve creation unit, 26D ... arterial curve shift processing unit 26E: Blood flow rate calculation means.

Claims (3)

造影剤が投与された被検体の関心部位をスキャンして得られた撮影時間の異なる複数の画像に基づいて脳組織内の血流を解析する脳血流解析装置において、
前記複数の画像から前記被検体の関心部位である脳組織内の動脈及び被検査部位の時間−造影剤濃度変化を表す動脈曲線及び被検査部位曲線を作成する変化曲線作成手段と、
この変化曲線作成手段により作成された動脈曲線を、前記被検査部位曲線よりも時間軸負方向へシフトする動脈曲線シフト処理手段と、
前記被検査部位の造影剤到達時刻が前記動脈よりも遅い血流伝達関数モデルに基づき、前記シフト後の前記動脈曲線と前記被検査部位曲線とから前記被検査部位の血流の平均通過時間を算出する手段と
を備えたことを特徴とする脳血流解析装置。
In a cerebral blood flow analysis device that analyzes blood flow in brain tissue based on a plurality of images with different imaging times obtained by scanning a region of interest of a subject to which a contrast agent is administered,
An arterial curve representing a time-contrast agent concentration change of an artery in a brain tissue that is a region of interest of the subject and a region to be examined from the plurality of images, and a change curve creating unit that creates a region to be examined;
Arterial curve shift processing means for shifting the arterial curve created by the change curve creating means in the negative direction of the time axis rather than the examination site curve;
Based on a blood flow transfer function model in which the contrast agent arrival time of the examination site is later than that of the artery, the average transit time of the blood flow of the examination site is calculated from the arterial curve and the examination site curve after the shift. A cerebral blood flow analysis device comprising: a calculating means.
請求項1に記載の脳血流解析装置において、
前記動脈曲線シフト処理手段は、前記シフト前の動脈曲線と前記被検査部位曲線との立ち上がり時刻を算出する立ち上がり時刻算出手段と、この立ち上がり時刻算出手段で算出された前記シフト前の動脈曲線の立ち上がり時刻が前記被検査部位曲線の立ち上がり時刻よりも遅いと判断したとき、前記シフト前の動脈曲線を当該被検査部位曲線の立ち上がり時刻よりも時間軸負方向へ平行にシフト移動する移動量を算出する手段と、この算出された移動量に従って前記シフト前の動脈曲線を時間軸負方向へシフトし、このシフト後の動脈曲線を算出する手段とを有することを特徴とする脳血流解析装置。
The cerebral blood flow analysis device according to claim 1,
The arterial curve shift processing means includes a rise time calculating means for calculating a rise time between the arterial curve before the shift and the region curve to be examined, and a rise of the arterial curve before the shift calculated by the rise time calculating means. When it is determined that the time is later than the rise time of the examination region curve, the amount of movement by which the arterial curve before the shift is shifted in parallel in the time axis negative direction from the rise time of the examination site curve is calculated. A cerebral blood flow analysis apparatus comprising: means; and means for shifting the arterial curve before the shift in the negative direction of the time axis in accordance with the calculated movement amount, and calculating the arterial curve after the shift.
請求項1に記載の脳血流解析装置において、
前記動脈曲線シフト処理手段は、予め前記シフト前の動脈曲線の立ち上がり時刻を、前記被検査部位曲線の立ち上がり時刻、あるいは撮影開始時刻まで時間軸負方向へシフトすることが定められている場合、前記シフト前の動脈曲線を前記被検査部位曲線の立ち上がり時刻、あるいは造影剤投与開始時刻まで時間軸負方向へ平行にシフト移動する移動量を算出する手段と、この算出された移動量に従って前記シフト前の動脈曲線を時間軸負方向へシフトし、このシフト後の動脈曲線を算出する手段とを有することを特徴とする脳血流解析装置。
The cerebral blood flow analysis device according to claim 1,
When the arterial curve shift processing means is determined in advance to shift the rise time of the arterial curve before the shift in the negative direction of the time axis until the rise time of the examination site curve or the imaging start time, Means for calculating a movement amount that shifts the arterial curve before the shift in parallel in the negative direction of the time axis until the rise time of the examination site curve or the contrast agent administration start time, and the pre-shift according to the calculated movement amount And a means for calculating the arterial curve after the shift in the negative direction of the time axis.
JP2008188979A 2008-07-22 2008-07-22 Cerebral blood flow analyzer Pending JP2010022667A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008188979A JP2010022667A (en) 2008-07-22 2008-07-22 Cerebral blood flow analyzer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008188979A JP2010022667A (en) 2008-07-22 2008-07-22 Cerebral blood flow analyzer

Publications (1)

Publication Number Publication Date
JP2010022667A true JP2010022667A (en) 2010-02-04

Family

ID=41729069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008188979A Pending JP2010022667A (en) 2008-07-22 2008-07-22 Cerebral blood flow analyzer

Country Status (1)

Country Link
JP (1) JP2010022667A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183775A1 (en) * 2012-06-07 2013-12-12 株式会社東芝 Image processing device and x-ray diagnostic device
CN106714689A (en) * 2014-09-22 2017-05-24 皇家飞利浦有限公司 Contrast arrival detection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06269424A (en) * 1993-03-16 1994-09-27 Toshiba Corp Medical image processor
JP2003116843A (en) * 2001-10-16 2003-04-22 Toshiba Corp Index calculation method, apparatus, and storage medium for blood flow dynamics of capillaries in brain tissue
JP2003190148A (en) * 2001-10-16 2003-07-08 Toshiba Corp Method and apparatus for calculating an index relating to local hemodynamics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06269424A (en) * 1993-03-16 1994-09-27 Toshiba Corp Medical image processor
JP2003116843A (en) * 2001-10-16 2003-04-22 Toshiba Corp Index calculation method, apparatus, and storage medium for blood flow dynamics of capillaries in brain tissue
JP2003190148A (en) * 2001-10-16 2003-07-08 Toshiba Corp Method and apparatus for calculating an index relating to local hemodynamics

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183775A1 (en) * 2012-06-07 2013-12-12 株式会社東芝 Image processing device and x-ray diagnostic device
JP2014012133A (en) * 2012-06-07 2014-01-23 Toshiba Corp Image processor and x-ray diagnostic device
CN104363834A (en) * 2012-06-07 2015-02-18 株式会社东芝 Image processing device and X-ray diagnostic device
US9433393B2 (en) 2012-06-07 2016-09-06 Toshiba Medical Systems Corporation Image processing apparatus and X-ray diagnosis apparatus
CN106714689A (en) * 2014-09-22 2017-05-24 皇家飞利浦有限公司 Contrast arrival detection
JP2017527402A (en) * 2014-09-22 2017-09-21 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Contrast arrival detection
US10499864B2 (en) 2014-09-22 2019-12-10 Koninklijke Philips N.V. Contrast arrival detection

Similar Documents

Publication Publication Date Title
EP1967140B1 (en) X-Ray CT-Apparatus, Myocardial Perfusion Information Generating System, X-Ray Diagnostic Method and Myocardial Perfusion Information Generating Method
US10966679B2 (en) Perfusion digital subtraction angiography
JP5322548B2 (en) X-ray CT apparatus, medical image processing apparatus, and medical image processing program
EP1970009B1 (en) Continuous x-ray image screening examination device, program, and recording medium
JP5643580B2 (en) Blood flow dynamic analysis device, blood flow dynamic analysis program, fluid analysis device, and fluid analysis program
EP2062532B1 (en) X-ray CT apparatus and myocardial perfusion image generating system
JP6981807B2 (en) Medical information processing device, X-ray CT device, medical information processing program, medical information processing method and medical information processing system
JP6021420B2 (en) Image processing apparatus, image processing method, and program
US9251560B2 (en) Medical image diagnosis apparatus and phase determination method using medical image diagnosis apparatus
US20060241402A1 (en) X-ray CT apparatus and myocardial perfusion image generating system
EP1604612B1 (en) X-ray CT apparatus for myocardial perfusion image generation
CN102711615B (en) X-ray diagnostic apparatus, image processing apparatus and image processing program
JP2012000135A (en) Multi-modality dynamic image diagnostic apparatus
JP2007167656A (en) Method of analyzing motion of object and tomography apparatus
JP5156863B2 (en) X-ray CT system
JP5388638B2 (en) Image processing apparatus and image processing program
JP2007151881A (en) Blood stream kinetics analyzing apparatus
JP2010154982A (en) X-ray computer tomographic imaging apparatus and image processor
JP4804039B2 (en) Blood flow dynamic analysis apparatus, X-ray CT apparatus, MRI apparatus, and blood flow dynamic analysis program
JP2010022667A (en) Cerebral blood flow analyzer
KR101638597B1 (en) Method and Apparatus for processing of medical images
JP2012000323A (en) 3d image forming apparatus, 3d image forming program and 3d image forming method
JP2005160102A (en) Method and apparatus for medical imaging
JP2006130141A (en) Cbf quantification method
JP2017158649A (en) Helical CT device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110721

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130709